Claims for Patent: 6,590,078

Summary for Patent: 6,590,078

Title:	DNA sequences, vectors, and fusion polypeptides for secretion of polypeptides in filamentous fungi
Abstract:	The invention includes novel fusion nucleic acids encoding fusion polypeptides which when expressed in a filamentous fungus result in the expression of fusion polypeptides. The fusion nucleic acids comprise four nucleic acids which encode a fusion polypeptide comprising first, second, third and fourth amino acid sequences. The first nucleic acid encodes a signal polypeptide functional as a secretory sequence in a first filamentous fungus. The second nucleic acid encodes a secreted polypeptide or functional portion thereof which is normally secreted from the same filamentous fungus or a second filamentous fungus. The third nucleic acid encodes a cleavable linker while the fourth nucleic acid comprises at least two nucleic acids encoding desired polypeptides.
Inventor(s):	Ward; Michael (San Francisco, CA), Power; Scott D. (San Bruno, CA)
Assignee:	Genencor International, Inc. (Palo Alto, CA)
Application Number:	09/912,733
Patent Claims:	1. A fusion polypeptide comprising, from an amino-terminus of said fusion polypeptide, first, second, third and fourth amino acid sequences, said first amino acid sequence comprising a signal polypeptide functional as a secretory sequence in a first filamentous fungus, said second amino acid sequence comprises a secreted polypeptide or functional portion thereof from said first or a second filamentous fungus, said third amino acid sequence comprises a cleavable linker and said fourth amino acid sequence comprises two or more desired polypeptides. 2. A fusion polypeptide comprising, from an amino-terminus of said fusion polypeptide, first, fifth, third and second amino acid sequences, wherein said first amino acid sequence comprises a signal polypeptide functional as a secretory sequence in a first filamentous fungus, said second amino acid sequence comprises a secreted polypeptide or functional portion thereof from said first or a second filamentous fungus, said third amino acid sequence comprises a cleavable linker and said fifth amino acid sequence comprises at least one desired polypeptide. 3. A fusion polypeptide comprising, from an amino-terminus of said fusion polypeptide: a) a first amino acid sequence comprising a signal polypeptide functional as a secretory sequence in a first filamentous fungus; b) a second amino acid sequence comprising first and second parts and comprising a secreted polypeptide or functional portion thereof normally secreted from said first or a second filamentous fungus; and c) an insertion amino acid sequence between said first and second parts comprising a fifth amino acid sequence flanked by third amino acid sequences; wherein said third amino acid sequences comprise cleavable linkers and said fifth amino acid sequence comprises at least one desired polypeptide. 4. A fusion polypeptide according to claim 1 wherein said two or more desired polypeptides of said fourth amino acid sequence are the same polypeptide. 5. A fusion polypeptide according to claim 1 wherein at least two of said two or more desired polypeptides of said fourth amino acid sequence are different polypeptides. 6. A fusion polypeptide according to claim 1 wherein said fourth amino acid sequence further comprises at least one cleavable linker, wherein said desired polypeptides are separated by said cleavable linker. 7. A fusion polypeptide according to claim 6 wherein said fourth amino acid sequence comprises at least three desired polypeptides and at least two cleavable linkers, wherein each of said desired polypeptides is separated by one of said cleavable linkers. 8. A fusion polypeptide according to claim 6 wherein said fourth amino acid sequence comprises at least four desired polypeptides and at least three cleavable linkers, wherein each of said desired polypeptides is separated by one of said cleavable linkers. 9. A fusion polypeptide according to claim 7 wherein said fourth amino acid sequence comprises at least four desired polypeptides and at least three cleavable linkers, wherein each of said cleavable linkers is positioned between desired polypeptides. 10. A fusion polypeptide comprising, from an amino-terminus of said fusion polypeptide: a) a first amino acid sequence comprising a signal polypeptide functional as a secretory sequence in a first filamentous fungus; b) a second amino acid sequence comprising first and second parts and comprising a secreted polypeptide or functional portion thereof from said first or a second filamentous fungus, wherein said secreted polypeptide contains a linker region; and c) an insertion amino acid sequence between said first and second parts of said second amino acid sequence comprising a fifth amino acid sequence flanked by third amino acid sequences, wherein the insertion point is within said linker region; wherein said third amino acid sequences comprise cleavable linkers and said fifth amino acid sequence comprises at least one desired polypeptide. 11. A fusion polypeptide according to claim 1, 2 or 3 wherein said first amino acid sequence comprises a signal polypeptide or portion thereof selected from the group consisting of signal polypeptides from glucoamylase, .alpha.-amylase, and aspartyl protease from Aspergillus species, signal polypeptides from bovine chymosin and human tissue plasminogen activator and signal polypeptides from Trichoderma cellobiohydrolase I and II. 12. A fusion polypeptide according to claim 11 wherein said first amino acid sequence comprises the signal polypeptide from Aspergillus awamori glucoamylase. 13. A fusion polypeptide according to claim 1, 2 or 3 wherein said second amino acid sequence comprises a secreted polypeptide selected from the group consisting of glucoamylase, .alpha.-amylase, and aspartyl protease from Aspergillus species and Trichoderma cellobiohydrolase I and II. 14. A fusion polypeptide according to claim 13 wherein said second amino acid sequence comprises at least the catalytic domain of glucoamylase from Aspergillus awamori. 15. A fusion polypeptide according to claim 13 wherein said second amino acid sequence comprises at least the catalytic domain and part of the linker region of glucoamylase from Aspergillus awamori. 16. A fusion polypeptide according to claim 1, 2 or 3 wherein said second amino acid sequence comprises glucoamylase from Aspergillus awamori. 17. A fusion polypeptide according to claim 1, 2 or 3 wherein said third amino acid sequence comprises a cleavable linker selected from the group consisting of the prosequence from chymosin, the prosequence of subtilisin, methionine, and sequences recognized by trypsin, factor X.sub.a, collagenase, clostripain, subtilisin and chymosin. 18. A fusion polypeptide according to claim 1, 2 or 3 wherein said cleavable linker is a sequence recognized by trypsin. 19. A fusion polypeptide according to claim 18 wherein said sequence recognized by trypsin is a lysine residue. 20. A fusion polypeptide according to claim 18 wherein said sequence recognized by trypsin is lysine-arginine. 21. A fusion polypeptide according to claim 1, 2 or 3 wherein said third amino acid sequence comprises a prosequence of chymosin or a portion thereof. 22. A fusion polypeptide according to claim 1, 2 or 3 wherein said fourth amino acid sequence comprises a desired polypeptide selected from the group consisting of enzymes, hormones, growth factors, cytokines, and serum proteins. 23. A fusion polypeptide according to claim 1, 2 or 3 wherein said fourth amino acid sequence comprises R3-hirulog.

Details for Patent 6,590,078

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2017-01-17